Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Hyaluronidase Treatment of Scleroderma-Induced Microstomia.

Melvin OG, Hunt KM, Jacobson ES.

JAMA Dermatol. 2019 May 29. doi: 10.1001/jamadermatol.2019.0585. [Epub ahead of print] No abstract available.

PMID:
31141116
2.

Successful treatment of refractory Hailey-Hailey disease with a 595-nm pulsed dye laser: a series of 7 cases.

Hunt KM, Jensen JD, Walsh SB, Helms ME, Soong VY, Jacobson ES, Sami N, Huang CC, Theos A, Northington ME.

J Am Acad Dermatol. 2015 Apr;72(4):735-7. doi: 10.1016/j.jaad.2014.12.023. No abstract available.

PMID:
25773417
3.

Effect of melanization upon porosity of the cryptococcal cell wall.

Jacobson ES, Ikeda R.

Med Mycol. 2005 Jun;43(4):327-33.

PMID:
16110778
4.

Mitochondrial functioning of constitutive iron uptake mutations in Cryptococcus neoformans.

Jacobson ES, Troy AJ, Nyhus KJ.

Mycopathologia. 2005 Jan;159(1):1-6.

PMID:
15750726
5.

Oxy2 as a transcriptional activator gene for copper uptake in Cryptococcus neoformans.

Nyhus K, Jacobson ES.

Med Mycol. 2004 Aug;42(4):325-31.

PMID:
15473357
6.

3-Hydroxyanthranilate in Cryptococcus neoformans: a secreted reductant that does not enable wood rot.

Jacobson ES, Milhausen SM, Manthey MK.

Med Mycol. 2003 Aug;41(4):309-20.

PMID:
12964724
7.

Effects of melanin upon susceptibility of Cryptococcus to antifungals.

Ikeda R, Sugita T, Jacobson ES, Shinoda T.

Microbiol Immunol. 2003;47(4):271-7.

8.
9.

Laccase and melanization in clinically important Cryptococcus species other than Cryptococcus neoformans.

Ikeda R, Sugita T, Jacobson ES, Shinoda T.

J Clin Microbiol. 2002 Apr;40(4):1214-8.

10.

Pathogenic roles for fungal melanins.

Jacobson ES.

Clin Microbiol Rev. 2000 Oct;13(4):708-17. Review.

12.

Ferrous iron uptake in Cryptococcus neoformans.

Jacobson ES, Goodner AP, Nyhus KJ.

Infect Immun. 1998 Sep;66(9):4169-75.

13.

Redox buffering by melanin and Fe(II) in Cryptococcus neoformans.

Jacobson ES, Hong JD.

J Bacteriol. 1997 Sep;179(17):5340-6.

14.

Ferric iron reduction by Cryptococcus neoformans.

Nyhus KJ, Wilborn AT, Jacobson ES.

Infect Immun. 1997 Feb;65(2):434-8.

15.

Discordant regulation of phenoloxidase and capsular polysaccharide in Cryptococcus neoformans.

Jacobson ES, Compton GM.

J Med Vet Mycol. 1996 Jul-Aug;34(4):289-91.

PMID:
8873890
16.

Structure of the O-deacetylated glucuronoxylomannan from Cryptococcus neoformans Cap70 as determined by 2D NMR spectroscopy.

Bacon BE, Cherniak R, Kwon-Chung KJ, Jacobson ES.

Carbohydr Res. 1996 Mar 22;283:95-110.

PMID:
8901265
17.

Antioxidant function of melanin in black fungi.

Jacobson ES, Hove E, Emery HS.

Infect Immun. 1995 Dec;63(12):4944-5.

18.

Genetic study of oxygen resistance and melanization in Cryptococcus neoformans.

Emery HS, Shelburne CP, Bowman JP, Fallon PG, Schulz CA, Jacobson ES.

Infect Immun. 1994 Dec;62(12):5694-7.

19.

Relationship between superoxide dismutase and melanin in a pathogenic fungus.

Jacobson ES, Jenkins ND, Todd JM.

Infect Immun. 1994 Sep;62(9):4085-6.

20.

Strains of Cryptococcus neoformans with defined capsular phenotypes.

Jacobson ES, Tingler MJ.

J Med Vet Mycol. 1994;32(5):401-4.

PMID:
7844706
21.

Potential molecular targets of metabolic pathways.

Boyle SM, Szaniszlo PJ, Nozawa Y, Jacobson ES, Cole GT.

J Med Vet Mycol. 1994;32 Suppl 1:79-89. Review. No abstract available.

PMID:
7722804
22.

Antioxidant function of fungal melanin.

Jacobson ES, Tinnell SB.

J Bacteriol. 1993 Nov;175(21):7102-4.

23.

Mannosyl transfer in Cryptococcus neoformans.

White CW, Jacobson ES.

Can J Microbiol. 1993 Jan;39(1):129-33.

PMID:
8439868
24.

Regulation of cryptococcal capsular polysaccharide by iron.

Vartivarian SE, Anaissie EJ, Cowart RE, Sprigg HA, Tingler MJ, Jacobson ES.

J Infect Dis. 1993 Jan;167(1):186-90.

PMID:
8418165
25.

Characterization of a phenol oxidase from Cryptococcus neoformans var. neoformans.

Ikeda R, Shinoda T, Morita T, Jacobson ES.

Microbiol Immunol. 1993;37(10):759-64.

26.

Heterogeneity of phenol oxidases in Cryptococcus neoformans.

Ikeda R, Jacobson ES.

Infect Immun. 1992 Sep;60(9):3552-5.

27.

Surgical management of perilymphatic fistulas: a Portland experience.

Black FO, Pesznecker S, Norton T, Fowler L, Lilly DJ, Shupert C, Hemenway WG, Peterka RJ, Jacobson ES.

Am J Otol. 1992 May;13(3):254-62. Review.

PMID:
1609855
28.

Iron assimilation in Cryptococcus neoformans.

Jacobson ES, Vartivarian SE.

J Med Vet Mycol. 1992;30(6):443-50.

PMID:
1287163
29.

Surgical management of perilymph fistulas. A new technique.

Black FO, Pesznecker S, Norton T, Fowler L, Lilly DJ, Shupert C, Hemenway WG, Peterka RJ, Jacobson ES.

Arch Otolaryngol Head Neck Surg. 1991 Jun;117(6):641-8. Review.

PMID:
2036186
30.

Temperature regulation of the cryptococcal phenoloxidase.

Jacobson ES, Emery HS.

J Med Vet Mycol. 1991;29(2):121-4.

PMID:
1908897
31.
32.
33.

Localization of mannoprotein in Cryptococcus neoformans.

Vartivarian SE, Reyes GH, Jacobson ES, James PG, Cherniak R, Mumaw VR, Tingler MJ.

J Bacteriol. 1989 Dec;171(12):6850-2.

34.

Effect of hypertonic solutes upon the polysaccharide capsule in Cryptococcus neoformans.

Jacobson ES, Tingler MJ, Quynn PL.

Mycoses. 1989 Jan;32(1):14-23.

PMID:
2664504
35.

Extracellular iron chelation in Cryptococcus neoformans.

Jacobson ES, Petro MJ.

J Med Vet Mycol. 1987 Dec;25(6):415-8.

PMID:
3325632
36.

Cryptococcal UDP-glucose dehydrogenase: enzymic control of capsular biosynthesis.

Jacobson ES.

J Med Vet Mycol. 1987 Jun;25(3):131-5.

PMID:
3302196
37.

Cytologic identification of trophoblastic epithelium in products of first-trimester abortion.

Jacobson ES, Goetsch M.

Obstet Gynecol. 1985 Jul;66(1):124-6.

PMID:
2409489
38.

Occurrence of diploid strains of Cryptococcus neoformans.

White CW, Jacobson ES.

J Bacteriol. 1985 Mar;161(3):1231-2.

39.

Recombinational mapping of capsule mutations in Cryptococcus neoformans.

Still CN, Jacobson ES.

J Bacteriol. 1983 Oct;156(1):460-2.

40.

Serologic tests for histoplasmosis.

Jacobson ES, Straus SE.

Ann Intern Med. 1983 Apr;98(4):560-1. No abstract available.

PMID:
6838087
41.
42.

Decreased virulence in stable, acapsular mutants of cryptococcus neoformans.

Fromtling RA, Shadomy HJ, Jacobson ES.

Mycopathologia. 1982 Jul 23;79(1):23-9.

PMID:
6750405
43.

Genetic and phenotypic characterization of capsule mutants of Cryptococcus neoformans.

Jacobson ES, Ayers DJ, Harrell AC, Nicholas CC.

J Bacteriol. 1982 Jun;150(3):1292-6.

44.

Cysteine-independent and cysteine-requiring yeast-strains of Histoplasma capsulatum.

Jacobson ES, Harrell AC.

Mycopathologia. 1982 Feb 19;77(2):69-73.

PMID:
7070482
45.

A prototrophic yeast-strain of Histoplasma capsulatum.

Jacobson ES, Harrell AC.

Mycopathologia. 1982 Feb 19;77(2):65-8. No abstract available.

PMID:
7070481
46.

Auxotrophic markers and the cytogenetics of Filobasidiella neoformans.

Kline MT, Jacobson ES.

Mycopathologia. 1981 Nov 11;76(2):115-7.

PMID:
7033793
47.

Reevaluation of diagnostic histoplasma serologies.

Jacobson ES, Straus SE.

Am J Med Sci. 1981 May-Jun;281(3):143-51.

PMID:
7246595
48.

Selenocystine-resistant mutants of Histoplasma capsulatum.

Jacobson ES, Harrell AC.

Mycopathologia. 1981 Mar 13;73(3):177-81.

PMID:
7219517
49.
50.

Auxotrophic mutants of Cryptococcus neoformans.

Jacobson ES, Ayers DJ.

J Bacteriol. 1979 Jul;139(1):318-9.

Supplemental Content

Loading ...
Support Center